Skip to content

Clinical trials

Phase 3 Hypoparathyroidism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypoparathyroidism Phase: Phase 3 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20091
20101
20113
20181
20214
20232
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting5
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire5
Ascendis Pharma Bone Diseases A/S2
Calcilytix Therapeutics, Inc., a BridgeBio company2
Alexion Pharmaceuticals, Inc.1
Ascendis Pharma A/S1
Columbia University1
MBX Biosciences1
National Institute of Dental and Craniofacial Research (NIDCR)1
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1
Saint Petersburg State University, Russia1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypoparathyroidism18
Endocrine System Diseases4
Hypocalcemia4
Parathyroid Diseases4
Hypercalciuria2
Calcium Metabolism Disorders1
Chronic Kidney Disease-Mineral and Bone Disorder1
DiGeorge Syndrome1
Hyperparathyroidism, Secondary1
Metabolic Diseases1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.